A combination therapy using two drugs could improve the life expectancy of melanoma sufferers, researchers say. The doubling up of two drugs significantly slows down the progression of the disease compared to when either drug is used alone.
Cancer Drugs Ipilimumab And Nivolumab, When Paired In Treatment, Significantly Slow Cancer Progression In Melanoma Patients
Tech Times - 1 Jun 2015 14:00
A combination therapy using two drugs could improve the life expectancy of melanoma sufferers, researchers say. The doubling up of two drugs significantly slows down the progression of the disease compared to when either drug is used alone.
Share this Article
Recommended